Artiam Bio, Inc. is a biotechnology company that is developing second generation type 1 cannabinoid receptor (CB1) antagonists to treat significant diseases. We are accelerating innovation to bring safe and effective treatment options.
We are focused on leveraging our core competency in cannabinoid receptor pharmacology to develop novel, small molecule drugs to help people whose lives are dramatically affected by severe diseases.
Company Details
- Founded
- 2020
- Address
- Morrisville, North Carolina 27560, Us
- Industry
- Biotechnology
- Website
- http://artiambio.net
- HQ
- Morrisville, North Carolina
Artiam Bio Inc. Questions
Artiam Bio Inc.'s website is http://artiambio.net
Artiam Bio Inc.'s LinkedIn profile is https://www.linkedin.com/company/artiambio
Artiam Bio Inc.'s industry is
Biotechnology
Artiam Bio Inc.'s top competitors are
University Of North Carolina At Chapel Hill,
Selsym Biotech,
Lumedica,
Divergene,
Idex Health & Science, Llc,
Curia Global,
Boundless Science,
Athembio,
Quadridox, Inc.,
Mimetics.
Artiam Bio Inc.'s categories are Biotechnology
Artiam Bio Inc.'s founding year is 2020
